Dr. Riam Shammaa Presents Pallianera Pharma at LSI USA '23

Transcription

Dr. Riam Shammaa  0:05  

Hello again. So my name is Riam. I'm the CEO of Pallianera. We're actually a commercial stage biotech company, we created a bio stimulating matrix that can be used in the applications of dermatology and cosmetics. We have a very dynamic young, but experienced team and myself, this is my third biotech company I created 3 15 years ago, one of them got acquired, and one of them IPOs. Of and we focus in Pallianera on specific philosophies that our patients are already good looking and beautiful. And our role is only to nudge them towards improving the quality of their skin towards healing and restoring their youthful glow. Now, unfortunately, or fortunately, in the last 10 years, fillers became the mainstay for treatments of aging. And we ended up with a with a sleigh of syndromes that I can't even pronounce from chipmunk face to a duck lip to an overfilled face. And I think the underlying problem was that we were trying to replace or fill a void, no pun intended in terms of trying to reverse aging of the skin. And aging of the skin is a disease and I'll show you how we tackle it by treating it. And not just by masking the problem. And that's where we come in our offering we offer to rejuvenate and regenerate the skin, we offer that IO stimulating matrix that is able to boost collagen and able to heal the wrinkles and stimulate stem cells in that skin. We focus on safety, natural aspects of the product and the beauty. And we focus on continuous regeneration of the skin. This is a massive market $29 billion in the US only by 2028. And it's a big market and difficult to distinguish yourself. So our focus actually is on being unique by offering a product that is the only one that would be able to regenerate the skin as well a product that is distinguished in terms of the branding and the offering and the message we deliver. Again, we drive with our patients that the fact that they are already beautiful, and we're not trying to alter who they are. But what we're trying to do is just help them restore that youthful glow, that volume and plumb by regenerating their their tissue. Now how does it work our technology we develop that by stimulating matrix which upon application leads to healing of the wrinkles, stimulating collagen production and increases naturally the volume of the skin. One of the things we tackled is that it can be applied in the same places that you apply a filler, so we did not have to retrain nurses and doctors on using the product. Now how it works, I'll explain it to you in four metrics. Usually when we look at skin quality, we look at four important metrics. Its thickness and density of the skin, roughness and brightness, hydration and elasticity. Now we showed studies that successfully were able to increase the recruitment of stem cells and migration of stem cells in the skin and that actually solves the problem of the density and thickness in this cannon start restoring the brightness. We also showed the successfully increasing the fibroblasts recruitment and proliferation in the skin. And we also showed that we are able to boost the production of collagen one which leads to improvement in elasticity and hydration. Now, what does this mean from a clinical perspective means when you apply it by stimulating matrix on a tissue, you are able to restore certain areas for example, under the eye this leads to increase of thickness and density. So lead to brightness. Disappearance of under the under the eyes bags. That means when you when you create a wrinkle, we are able to successfully eliminate that wrinkle or significantly decrease it by increasing that elasticity. And those are before and afters that you see are not immediate. Those are ones that were taken three months and six months after. Now we have our own patents and we have already our approvals from the FDA and Health Canada. And we are in a very big market quite competitive with with big players. Interestingly enough, early on, we were invited for discussions of acquisition but we believe it's quite early and we have so much potential to grow. In fact, we embarked on this trip and so far we have 400% growth year over year we have more than 100 clinics in North American expanding. We make an average of more than 3,000% for every product we sell, and we're raising $20 million mainly to expand sales globally and marketing. This upcoming generation is a generation that is way more focused on wellness, health and natural beauty. And we plan on being the number one provider for cosmetic products and procedures for this market. Thank you